These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
229 related items for PubMed ID: 21710853
1. Longitudinal ocular survey of 202 Filipino patients with multi-bacillary (MB) leprosy treated with 2 year WHO-multiple drug therapy. Ravanes JM, Cellona RV, Balagon M, Abalos RM, Walsh GP, Walsh DS. Southeast Asian J Trop Med Public Health; 2011 Mar; 42(2):323-30. PubMed ID: 21710853 [Abstract] [Full Text] [Related]
2. Relapse study in smear positive multibacillary (MB) leprosy after 1 year WHO-multi-drug therapy (MDT) in Cebu, Philippines. Maghanoy A, Mallari I, Balagon M, Saunderson P. Lepr Rev; 2011 Mar; 82(1):65-9. PubMed ID: 21644473 [Abstract] [Full Text] [Related]
3. Daily multidrug therapy for leprosy; results of a fourteen-year experience. de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B. Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752 [Abstract] [Full Text] [Related]
4. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil. Cunha Mda G, Virmond M, Schettini AP, Cruz RC, Ura S, Ghuidella C, Viana Fdos R, Avelleira JC, Campos AA, Filho B. Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027 [Abstract] [Full Text] [Related]
6. Six years' follow-up of multibacillary leprosy patients treated with uniform multi-drug therapy in China. Shen J, Yan L, Yu M, Li J, Yu X, Zhang G. Int J Dermatol; 2015 Mar; 54(3):315-8. PubMed ID: 25265933 [Abstract] [Full Text] [Related]
11. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Jing Z, Zhang R, Zhou D, Chen J. Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621 [Abstract] [Full Text] [Related]
12. International open trial of uniform multi-drug therapy regimen for 6 months for all types of leprosy patients: rationale, design and preliminary results. Kroger A, Pannikar V, Htoon MT, Jamesh A, Katoch K, Krishnamurthy P, Ramalingam K, Jianping S, Jadhav V, Gupte MD, Manickam P. Trop Med Int Health; 2008 May; 13(5):594-602. PubMed ID: 18346026 [Abstract] [Full Text] [Related]
18. Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results. Mane I, Cartel JL, Grosset JH. Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):224-9. PubMed ID: 9251595 [Abstract] [Full Text] [Related]
19. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences]. Millan J, Roux G, Loko S, Naudin JC, Boucher P, Bodian M, Camara M, Moreira-Diop T, Grosset J. Acta Leprol; 1986 Jun; 4(4):427-44. PubMed ID: 3296613 [Abstract] [Full Text] [Related]